Decision Looms That Could Determine Fate of Alzheimer’s Drug by BY PAM BELLUCK


Medicare officials are trying to determine whether to cover Aduhelm, which the F.D.A. approved despite unclear evidence that it helps patients.

Published: December 31, 2021 at 05:40PM

from NYT Health https://ift.tt/3JtLZWh